Botulinum Toxin Injection in Hypercontractile Esophagus
Status:
Completed
Trial end date:
2018-02-01
Target enrollment:
Participant gender:
Summary
This study aims to evaluate the efficacy and the safety of endoscopic injection of 100 IU of
botulinum toxin (BTX) in the distal esophagus in patients with symptoms related to
hypercontractile esophageal motility disorders.